{"id":689726,"date":"2024-02-29T00:00:02","date_gmt":"2024-02-29T00:00:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=689726"},"modified":"2024-02-29T00:00:02","modified_gmt":"2024-02-29T00:00:02","slug":"the-iv-catheters-market-to-reach-66-billion-by-2029-exclusive-focus-insight-report-by-arizton","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/the-iv-catheters-market-to-reach-66-billion-by-2029-exclusive-focus-insight-report-by-arizton_689726.html","title":{"rendered":"The IV Catheters Market to Reach $6.6 Billion by 2029 – Exclusive Focus Insight Report by Arizton"},"content":{"rendered":"
\n
\"The<\/a><\/div>\n
\n
Global Prebiotics Market Focus Insight Report by Arizton<\/div>\n<\/div>\n<\/div>\n
Get this Report for Lesser with Our Subscription Services<\/div>\n

According to Arizton’s latest focus insight report, the IV catheters market<\/a> is growing at a CAGR of 5.04% during 2023-2029.<\/p>\n

To Know More, Download the Free Sample Report:<\/strong> https:\/\/www.focusreports.store\/request-sample\/global-iv-catheters-market-focused-insights<\/strong><\/a><\/p>\n

IV Catheters Market Report Scope<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n
\n

Report Attributes<\/strong><\/p>\n<\/td>\n

\n

Details<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Market Size (2029)\u202f <\/strong><\/p>\n<\/td>\n

\n

$6.6 Billion<\/p>\n<\/td>\n<\/tr>\n

\n

Market Size (2023)<\/strong><\/p>\n<\/td>\n

\n

$4.9 Billion<\/p>\n<\/td>\n<\/tr>\n

\n

CAGR (2023-2029)\u202f <\/strong><\/p>\n<\/td>\n

\n

5.04%<\/p>\n<\/td>\n<\/tr>\n

\n

Historic Year<\/strong><\/p>\n<\/td>\n

\n

2020-2021<\/p>\n<\/td>\n<\/tr>\n

\n

Base Year<\/strong><\/p>\n<\/td>\n

\n

2022<\/p>\n<\/td>\n<\/tr>\n

\n

Forecast Year<\/strong><\/p>\n<\/td>\n

\n

2023-2029<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

In 2023, the global intravenous catheters market was dominated by North America, with a share of 33.45%. This region has a large presence of major vendors offering various IVCs to patients of various age groups. Further, this growing usage of IVCs in the region is being contributed by advanced healthcare infrastructure and growing awareness regarding the safety of IVCs. Europe is expected to witness the highest incremental growth of $513.50 million, and APAC is expected to record the highest absolute growth of 41.05% during the forecast period.<\/p>\n

With growing advancements and the need to reduce needlestick injuries, vendors are offering safety PIVCs and conventional PIVCs, competing based on cost, safety features, convenient use, marketing strategies, and distribution channels. The key vendors in the market include BD, Smith Medical, Vygon, B. Braun Melsungen AG, Teleflex, Terumo, and Shanghai Puyi Medical Instruments. Though major players dominate the market, others also focus on continuously developing low-cost and conventional PIVCs. In addition, a few regional companies are also coming into existence with innovative products and technologies. For instance, retrieving needles automatically after usage by retractable technologies is gaining traction among end-users.<\/p>\n

Moreover, vendors, especially global players, are increasingly pursuing inorganic growth strategies such as acquisitions and strategic partnerships to expand their presence, enhance product portfolio, and improve expertise in the market. For instance, Smith’s Medical acquired Access Scientific, a broad-spectrum vascular access and infection prevention company that manufactures POWERWAND midline and extended dwell catheters. BD acquired Velano Vascular, whose needle-free technology enables high-quality blood draws from existing PIVC lines. <\/p>\n

SEGMENTATION & FORECAST <\/strong><\/p>\n